Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.

D'Arrigo JS

Open source

DOI: 10.1177/1533317520976761
Published: 2020 Jan-Dec
Container: American journal of Alzheimer's disease and other dementias
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1533317520976761,
  title = {Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.},
  author = {D'Arrigo JS},
  year = {2020},
  journal = {American journal of Alzheimer's disease and other dementias},
  doi = {10.1177/1533317520976761},
  url = {https://doi.org/10.1177/1533317520976761}
}

RIS

TY  - JOUR
TI  - Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
AU  - D'Arrigo JS
PY  - 2020
JO  - American journal of Alzheimer's disease and other dementias
DO  - 10.1177/1533317520976761
UR  - https://doi.org/10.1177/1533317520976761
ER  -

APA

JS, D. (2020). Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.. American journal of Alzheimer's disease and other dementias. https://doi.org/10.1177/1533317520976761

Source records

pubmed · retrieved 2026-09-25T11:28:59.532Z
europe-pmc · retrieved 2026-09-25T11:28:59.545Z
doaj · retrieved 2026-09-25T11:28:59.524Z